马应龙：公司全资子公司马应龙美康收到国家药监局核准签发的玻璃酸钠滴眼液的药品注册证书。

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug registration certificate of sodium hyaluronate eye drops [1] Group 1 - The company's wholly-owned subsidiary, Mayinglong Meikang, has been granted the drug registration certificate [1]